| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 14 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - | |
| Dir | 13.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 1,644 | $12.28 | $20,188.32 | -6.2% | |
| Apr 1, 2016 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 1,685 | $6.62 | $11,154.70 | -8.0% | |
| Mar 10, 2016 | Lidgard Graham Peter | Chief Science Officer | Sale+OE | 3,041 | $6.05 | $18,398.05 | -1.3% | |
| Mar 10, 2016 | Arora Maneesh | COO | Sale+OE | 4,042 | $6.05 | $24,454.10 | -1.5% | |
| Mar 10, 2016 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 2,175 | $6.05 | $13,158.75 | -11.8% | |
| Mar 8, 2016 | Doyle James Edward75 | Director | Buy | 5,000 | $6.43 | $32,150.00 | +30.4% | |
| Mar 3, 2016 | Napier Katherine S50 | Director | Buy | 3,775 | $5.38 | $20,296.67 | +4.3% | |
| Mar 1, 2016 | Conroy Kevin T81 | President And CEO | Buy | 50,000 | $5.00 | $250,000.00 | +7.8% | |
| Feb 26, 2016 | Conroy Kevin T81 | President And CEO | Sell | 6,895 | $5.81 | $40,059.95 | -1.1% | |
| Feb 25, 2016 | Arora Maneesh | COO | Sale+OE | 4,099 | $5.52 | $22,626.48 | -1.5% |